Fatigue Severity Scale for Patients with Systemic Lupus Erythematosus--Chinese Version

2019 ◽  
Author(s):  
Chenchen Feng ◽  
Qian He ◽  
Yan Wu ◽  
Xiaokun Hu ◽  
Juan Wu ◽  
...  
2019 ◽  
Vol 11 (2) ◽  
Author(s):  
Thea Yovita ◽  
Sumartini Dewi ◽  
Sunaryo Barki Sastradimaja

Background Systemic Lupus Erythematosus (SLE) is a multifactorial and heterogenous systemic autoimmune disease, involving multisystem organ and marked with the production of autoantibodies. SLE has general constitutional sympton such as fatigue and usually is the main symptom causing limited functional condition on patients. Assessment for cardiorespiratory fitness can be done with various methods, one of them measuring Metabolic Equivalents (METs). The purpose of this study was to examine the correlation between cardiorespiratory fitness and Fatigue Severity Scale (FSS). Method The sampling method used was the total sampling method. Out-patients diagnosed with SLE were screened via medical records according to inclusion and exclusion criteria. SLE patients filled an Indonesian version of the FSS questionnaire sheet and did the six-minute walk test based on standard protocol on a 30-meter track. The total distance patients had crossed was turned into VO2 max with Nury equation, then turned again into cardiorespiratory fitness with METs unit. A correlation analysis between cardiorespiratory fitness and FSS was done next. Results There were 28 patients participating in this research. Correlation analysis resulted in a negative correlation with no statistical meaning between cardiorespiratory fitness and FSS (r = -0,27; p > 0,05). Conclusion There is no correlation between cardiorespiratory fitness and FSS in SLE patients. Keywords Correlation, Cardiorespiratory Fitness, Fatigue Severity Scale, Systemic Lupus Erythematosus


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
A Rifa’i ◽  
Handono Kalim ◽  
Kusworini Handono ◽  
Cesarius Singgih Wahono

Background: Fatigue is one symptom of Systemic Lupus Erythematosus (SLE), which has an important effect on the quality of life. Fatigue Severity Scale (FSS)is one parameter fatigue symptom in SLE. The purpose of this study was to determine the validity and reliabilitybetween FSS with duration of ilness and disease activity of SLE patients in Indonesia.Methods: FSS performed on 40 patients with SLE. FSS original English version has been converted-translated into Indonesian version by a team of RheumatologyImmunology Medical Faculty of Brawijaya University. Reliability determined by Cronbach’s Alpha values (>0.6). Validity was determined by the value of Corrected Item-Total Correlation which each item was a valid question if below value of Cronbach’s Alpha.Results: The reliability value was determined by Cronbach’s Alpha values (>0.6) in which the SLE patients in this study had a Cronbach’s Alpha value of 0.946. Value of Corrected Item-Total Correlation overall under Cronbach’s Alpha value (range = 0.684-0.859) which indicates that each item was a valid question. There were correlation between the FSS Indonesian version with disease duration (p = 0.000) as well as the value of r = 0.581, with SLEDAI (p = 0.000) with a value of r = 0.833. Conclusion: FSS in Indonesian version has a good reliability and validity and can be used by clinicians andother researchers to assess the condition of fatigue in SLE patients in Indonesia.Keywords: validity, reliability, fatigue, fatigue severity scale, systemic lupus erythematosus


2019 ◽  
Vol 46 (11) ◽  
pp. 1470-1477 ◽  
Author(s):  
Ariane Barbacki ◽  
Michelle Petri ◽  
Antonio Aviña-Zubieta ◽  
Graciela S. Alarcón ◽  
Sasha Bernatsky

Objective.Fatigue is a frequent, disabling issue in systemic lupus erythematosus (SLE). It is, however, difficult to quantify. The Ad Hoc Committee on SLE Response Criteria for Fatigue in 2007 recommended using the Krupp Fatigue Severity Scale (FSS). Since then, the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale has also been validated in SLE. We performed a review of instruments used to measure fatigue in adult SLE patients from 2007 onward.Methods.We searched PubMed, Medline, and Embase (January 2008–October 2017), identifying clinical trials and observational studies in adult SLE, where fatigue was a specifically measured outcome. All English and French studies were reviewed to determine fatigue measures and results.Results.Thirty-seven studies met inclusion criteria. Eight scales were used. The visual analog scale (VAS), FSS, and FACIT-Fatigue Scale were most frequent. FSS was the most often used instrument in both clinical trials and observational studies. Twenty-five of the 37 studies demonstrated a difference in fatigue that was statistically significant and clinically meaningful. Of the 12 studies that did not, 6 used FSS, 3 used VAS, 2 used the Multidimensional Assessment of Fatigue, and 1 used the Brief Fatigue Index. All 6 studies using the FACIT-Fatigue Scale detected clinically meaningful and statistically significant differences.Conclusion.VAS, FSS, and FACIT-Fatigue Scale were the most frequently used instruments in adult SLE studies from 2008 to 2017. Many studies detected clinically important changes in fatigue. Fatigue remains a key measure in both clinical trials and observational SLE studies.


Author(s):  
Antonietta Gigante ◽  
Francesco Iannazzo ◽  
Luca Navarini ◽  
Maria Chiara Sgariglia ◽  
Domenico Paolo Emanuele Margiotta ◽  
...  

Abstract Introduction Aims of study were to evaluate the prevalence of metabolic syndrome (MetS) in systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) patients and to evaluate serum level of adipokines in SLE and SSc patients with and without MetS. Methods Fifty SLE patients and 85 SSc patients were enrolled. The diagnosis of MetS was made according to the criteria of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. Clinical assessment and serum levels of adiponectin and resistin were evaluate in SLE and SSc patients. Results Prevalence of MetS was significantly (p<0.0001) higher in SLE patients than SSc patients (36% vs 10.6%). Median values of resistin were significantly (p<0.001) higher in SLE patients with MetS than SLE patients without MetS [4.01 ng/mL (2.7–4.5) vs 1.92 ng/mL (1.2–3)]. Median values of adiponectin were significantly (p<0.05) lower in SLE patients with MetS than SLE patients without MetS [5.64 ng/mL (4.96–8) vs 8.38 ng/mL (6.54–11.01)]. Systemic Lupus Erythematosus Activity Index [8 (6–12) vs 10 (6–13), p<0.01] and Systemic Damage Index [2 (1–3) vs 2 (0–3), p<0.001] were significantly higher in MetS patients than in patients without MetS. In SSc, the median value of disease severity scale was significantly higher (p<0.05) in MetS patients than in patients without MetS [7 (5–7) vs 5 (3–6)]. Conclusion Prevalence of MetS is higher in SLE patients. In SLE patients, MetS showed an association with adipokine levels and inflammation/activity disease scores. In SSc patients, MetS was associated with severity of disease. Key Points• Prevalence of metabolic syndrome is higher in SLE patients than SSc patients.• Resistin is higher in SLE patients with metabolic syndrome.• Adineponectin is lower in SLE patients with metabolic syndrome.• Disease severity scale is higher in SSc patients with metabolic syndrome.


2021 ◽  
Author(s):  
Lei Pan ◽  
Chenyu Zhang ◽  
Yan Huang ◽  
Huiqin Xi

Abstract Objectives:To examine the responsiveness, reliability, and validity of Chinese version of Systemic Lupus Erythematosus Questionnaire (SLAQ). Methods:A cross-sectional observational study was designed for this research. The principal attributes evaluated were linguistic and cultural adaption, reliability, and validity.Standardized response means and acceptability were calculated to estimate the responsiveness of the SLAQ. Cronbach’s alpha was used to evaluate its reliability. The Spearman correlation coefficient was used to assess the criterion validity by calculating the association with measurement of other lupus disease activity.ResultsThe response rate for the pilot study was 99.9%. The mean time to complete the questionnaire was 6.7±2.8 min. The Chinese version of SLAQ had good reliability, with a Cronbach’s alpha of 0.857. Cronbach’s alpha for the test-retest reliability was 0.878. For validity, the SLAQ was correlated with SLAM, SLEDAI-2000 and SLEDAI-no lab. The correlation was good at 0.832, 0.506 and 0.668 respectively.Conclusion:The Chinese version of the SLAQ questionnaire has adequate responsiveness, reliability, and validity in our cohort, and it is a helpful and meaningful tool for assessing disease activity in lupus patients without laboratory results.


Medicine ◽  
2021 ◽  
Vol 100 (7) ◽  
pp. e24849
Author(s):  
Haoyang Chen ◽  
Xin Chen ◽  
Hongyan Yan ◽  
Jielin Ben ◽  
Xiaoyan Yao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document